The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM

Launched by HOSPITAL DE CLINICAS DE PORTO ALEGRE · Jun 17, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how a special assessment tool can help doctors make better treatment plans for elderly patients with type 2 diabetes (T2DM). As people age, they often face challenges such as frailty, which can worsen their diabetes management and overall health. The trial aims to see if using a geriatric assessment, which looks at a patient’s health and functional abilities, can lead to more personalized and effective diabetes care.

To be eligible for this trial, participants must be 60 years or older, diagnosed with type 2 diabetes, and currently receiving care at a specialized endocrinology clinic. Those who join will undergo a comprehensive health assessment and will be randomly assigned to either receive usual care or care that includes the results of the geriatric assessment. Over the next few months, researchers will check in with participants to see how their treatment is working and whether it affects their risk of problems like low blood sugar, falls, or hospital visits. This trial is important because it could help create better, more tailored diabetes treatment plans for older adults.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 60 years or older
• • Diagnostic of type 2 diabetes mellitus according to American Diabetes Association criteria
• • Patients under follow-up in a specialized endocrinology outpatient clinic
• • Patients who have a glycated hemoglobin measurement of up to one month
• Exclusion Criteria:
• • Lack of consent for research participation from the patient or the physician
• • Patients classified as Clinical Frailty Scale 9.